China Nepstar Chain Drugstore (China Nepstar Chain Drugstore) Asset Impairment Charge : $0.0 Mil (TTM As of Mar. 2016)

View and export this data going back to 2007. Start your Free Trial

What is China Nepstar Chain Drugstore Asset Impairment Charge?

China Nepstar Chain Drugstore's Asset Impairment Charge for the three months ended in Mar. 2016 was $0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2016 was $0.0 Mil.

China Nepstar Chain Drugstore Asset Impairment Charge Historical Data

The historical data trend for China Nepstar Chain Drugstore's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Nepstar Chain Drugstore Asset Impairment Charge Chart

China Nepstar Chain Drugstore Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Asset Impairment Charge

Get a 7-Day Free Trial

China Nepstar Chain Drugstore Quarterly Data
	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

China Nepstar Chain Drugstore Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

China Nepstar Chain Drugstore Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of China Nepstar Chain Drugstore's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

China Nepstar Chain Drugstore (China Nepstar Chain Drugstore) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Nepstar Chain Drugstore Ltd (NYSE:NPD) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.nepstar.cn

China Nepstar Chain Drugstore Ltd was incorporated in the Cayman Islands in August 2004. The Company operates retail drugstore business. The Company provides professional and convenient pharmacy services and other merchandise, including over-the-counter drugs, nutritional supplements, herbal products, personal care products, family care products, as well as convenience products including consumable, seasonal and promotional items. It also offers private label products. The Company offers 523 nutritional supplements, including a variety of healthcare supplements, vitamins, minerals and dietary products. Its other products include personal care products such as skin care, hair care and beauty products, family care products such as portable medical devices for family use, birth control and early pregnancy test products, and convenience products, including soft drinks, packaged snacks, cleaning agents and stationery. The other products also include seasonal and promotional items tailored to local consumer demand for convenience and quality. The Company also provides ancillary services such as providing free blood pressure measurements in its stores. The Company competes with other retail drugstore chains or independent drugstores. As a distributor and retailer of pharmaceutical products, the Company is subject to regulation and oversight by different levels of the food and drug administration in China, in particular, the State Food and Drug Administration, or the SFDA.

China Nepstar Chain Drugstore (China Nepstar Chain Drugstore) Headlines

From GuruFocus

High Yield George Soros Stocks: China Nepstar ADS, Chimera Investment, PDL BioPharma, MFA Mortgage Investments, Windstream Corp.

By Buffetteer Buffetteer • 04-23-2010